DDDI Section 


Join today! 

The Drug Discovery and Development Interface (DDDI) section focuses on issues at the critical interface between drug discovery and drug development and provides a collaborative forum for interactions among scientists from academia, industry (large and small pharma), and government institutions. DDDI welcomes participation of all AAPS members (as well as colleagues from other professional organizations) whose efforts are directed toward discovering, optimizing, and effectively transitioning preclinical candidates into the clinical development phase.

Find us on



Participate in DDDI's mentoring program »

Call for Screeners
Volunteer to screen contributed papers submitted to the 2015 AAPS National Biotechnology Conference. Training material, the topic structure outline, and screening tips are available on the contributed papers webpage.
Application deadline: March 4, 2015

Call for Fellow Nominations » 
Nomination deadline: March 27, 2015

AAPS DDDI Section Meeting—Drug Discovery Paradigm Shift? »
May 29, 2015
Merck & Co., Inc., Upper Gwynedd, Pa.